ArticleQuantitative imaging in medicine and surgery2026
Doppler ultrasound for the evaluation of chronic renal allograft dysfunction.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic renal allograft dysfunction (CRAD) is a common cause of late graft failure after kidney transplantation. Puncture biopsy is the "gold standard" for the diagnosis and assessment of CRAD, but can easily lead to various complications. Thus, this study sought to identify Doppler ultrasound parameters that can accurately assess CRAD. Methods: Kidney transplant recipients who underwent ultrasound Doppler examination between January 2011 and December 2021 at our hospital were included in the study. The CRAD group comprised patients who underwent pathology puncture within 7 days of Doppler ultrasonography and were diagnosed with chronic pathological changes by two specialized pathologists. The patients in the GRAD group were further subdivided into mild (group I) and moderate-to-severe (group II) groups based on the degree of pathological changes. Data on sex, age, body mass index (BMI), blood pressure, the estimated glomerular filtration rate (eGFR), serum creatinine (SCr), and cystatin-c (Cys-C) from three days before and after each patient's ultrasound examination were collected from the hospital's electronic medical record system. The Doppler ultrasound blood flow parameters of the transplanted kidneys were obtained using an ultrasound imaging system, and two specialized sonographers assessed the quality of the images, and images with satisfactory quality were deemed valid. Spearman rank correlation was used to analyze the relationships between the parameters. A logistic regression analysis was conducted to identify the independent significant variables. Prediction models were assessed by receiver operating characteristic (ROC) curves. Results: A total of 188 transplanted kidney recipients were included in this study. The CRAD group comprised 92 patients (group I comprised 45 patients and group II comprised 47 patients), aged 18-68 years, of whom, 75 were male and 17 were female. The control group comprised 96 patients, aged 19-63 years, of whom, 75 were male and 21 were female. With the exception of the arcuate artery, moderate negative correlations were observed between the end-diastolic velocity (EDV) of all the arteries and Cys-C ( Conclusions: Among the Doppler ultrasound parameters, the RI of the renal artery and the EDV of the segmental artery were the most useful in the diagnosis of CRAD. Further, the combination of the EDV of the segmental artery and kidney length showed significant potential in assessing pathological changes in CRAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.